DLH Holdings Corp

DLH Holdings Corp (DLHC) Stock Analysis

$3.610

-0.020 (-0.55%)At close

Loading chart…
High
3.690
Open
3.545
VWAP
3.62
Volume
3.78K
Mkt Cap
152.43M
Low
3.545
Amount
13.66K
EV/EBITDA, TTM
144.26

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

AI analysis of DLH Holdings Corp (DLHC)

Buy

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

Analyst Ratings (2)

+177.01% upside
Buy
2 Buy
0 Hold
0 Sell
Current: 3.61
Low
10.00
Average
10.00
High
10.00

Noble Capital

2026-07-31

Price Target

$7

Outperform

Noble Capital

2025-05-09

Price Target

$10

Outperform

Valuation Metrics

The current forward P/E ratio for DLH Holdings Corp (DLHC) is 17.45, compared to its 5-year average forward P/E of 9.20.

Forward P/E

Fair
5Y Average P/E
9.20
Current P/E
17.45
Overvalued
34.86
Undervalued
-16.46

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
15.86
Current EV/EBITDA
144.26
Overvalued
48.31
Undervalued
-16.58

Forward P/S

Fair
5Y Average P/S
0.41
Current P/S
0.30
Overvalued
0.55
Undervalued
0.28

Alphio AI Price Scenarios for DLHC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%DLHC

$5.55

Scenario price

B

Base

Base · 50%DLHC

$4.96

Scenario price

B

Bear

Bear · 25%DLHC

$4.16

Scenario price

Events Timeline

2026-10-05 (ET)

09:00:00

DLH Holdings Awarded NIH Data Governance Framework Task Order

2026-09-28 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth Up to $19.1M from NIH

2026-09-16 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth $43.7M

2026-06-30 (ET)

16:30:00

DLH Holdings Appoints Kathryn JohnBull as New CEO

2026-06-25 (ET)

16:30:00

DLH Holdings Awarded U.S. Navy Logistics IT Contract Worth $250M

News

DLHC FAQ — answered by Alphio AI

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems. It operates in the Technology sector (SERVICES-HELP SUPPLY SERVICES industry).

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

2 analysts cover DLHC: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading